HCWB

HCW Biologics Inc. NASDAQ Listed Jul 20, 2021

Healthcare ·Biotechnology ·US · hcwbiologics.com

$0.32

Mkt Cap $667,888

52w Low $0.25 0.4% of range 52w High $17.80

50d MA $0.48 200d MA $2.31

P/E (TTM) -0.0x

EV/EBITDA -1.2x

P/B 0.3x

Debt/Equity 2.5x

ROE -287.9%

P/FCF -0.2x

RSI (14) —

ATR (14) —

Beta 0.91

50d MA $0.48

200d MA $2.31

Avg Volume 9.0M

HCW Biologics Inc., a preclinical stage biopharmaceutical company, focuses on discovering and developing novel immunotherapies for chronic, low-grade inflammation, and age-related diseases. The company's lead products include HCW9218, which is an injectable immunotherapeutic for patients with pancreatic, ovarian, breast, prostate, and colorectal cancers, as well as pulmonary fibrosis; and HCW9302 for auto-immune diseases, such as alopecia areata and metabolic diseases. It also develops HCW9201, a cell-based therapy that is in Phase II clinical trials for the treatment of patients with relapsed/refractory acute myeloid leukemia; and HCW9206 for the treatment of acute myeloid leukemia. The company was incorporated in 2018 and is headquartered in Miramar, Florida.

SIC Code

2834

CIK (SEC)

1828673

Phone

954 842 2024

2929 North Commerce Parkway · Miramar, FL 33025 · US

Date	Time	Est	Rptd	Surp	Base	Gap%	D1%	D2%	D3%	D4%	D5%	Guide ▲★
Mar 31, 2026	AMC	-0.84	-2.63	-213.1%	0.36	-8.3%	-16.7%	-10.7%	+7.3%	-5.0%	+20.2%	—
Nov 14, 2025	AMC	1.58	-2.02	-227.8%	3.00	+0.7%	+2.0%	-21.2%	-17.0%	-4.0%	+13.0%	—
Aug 18, 2025	AMC	1.80	-6.79	-477.2%	4.02	-10.0%	-11.4%	-4.5%	-2.6%	+4.2%	+60.9%	—
May 15, 2025	AMC	—	-0.05	—	8.20	+0.0%	+9.1%	-4.2%	+7.1%	-5.2%	-4.5%	—
Mar 28, 2025	AMC	3.60	-3.20	-188.9%	12.00	-5.7%	-6.0%	-0.4%	+0.3%	-15.3%	-4.8%	—
Nov 14, 2024	AMC	-5.20	-4.00	+23.1%	12.36	-8.4%	-4.7%	+321.1%	-11.3%	-13.9%	-25.1%	—
Aug 14, 2024	AMC	-7.20	-16.00	-122.2%	23.20	-13.8%	-13.6%	-0.2%	+0.0%	-11.0%	-3.6%	—
May 15, 2024	AMC	—	-8.00	—	46.40	-4.3%	-5.2%	+0.0%	+0.9%	+0.0%	+0.0%	—
Mar 26, 2024	AMC	—	-0.15	—	68.00	-4.1%	+3.5%	-0.6%	-5.7%	+0.6%	+0.0%	—
Nov 14, 2023	AMC	-0.13	-5.60	-4207.7%	46.40	+0.0%	-20.7%	+15.2%	+3.3%	-1.4%	+0.9%	—
Aug 11, 2023	AMC	-0.15	-4.80	-3100.0%	84.80	-1.7%	+0.5%	-2.2%	+0.8%	-3.8%	-0.0%	—
May 9, 2023	AMC	-0.14	-5.60	-3900.0%	59.60	-4.3%	+3.4%	-2.6%	+1.3%	-3.3%	+1.0%	—

Date	Firm	Action	Grade	Target	Base	Open	Gap%	D1%	D2%	D3%	D4%	D5%
May 29	Maxim Group	Maintains	Buy → Buy	—	$8.00	$8.00	+0.0%	+0.2%	-3.6%	-6.7%	-7.1%	-8.4%
Apr 19	EF Hutton	Maintains	Buy → Buy	—	$59.60	$58.40	-2.0%	-2.0%	-6.2%	+1.1%	+2.2%	-1.4%
Mar 30	EF Hutton	Maintains	Buy → Buy	—	$58.40	$62.40	+6.8%	-8.9%	+5.3%	-2.9%	+3.7%	+2.8%
Mar 23	EF Hutton	Maintains	Buy → Buy	—	$54.00	$60.80	+12.6%	+7.4%	-4.1%	-1.8%	-2.6%	+9.8%
Nov 8	JonesTrading	Maintains	Buy → Buy	—	$91.20	$89.60	-1.8%	-2.3%	+4.1%	-3.0%	-3.1%	-1.1%
Mar 24	Maxim Group	Maintains	Buy → Buy	—	$91.20	$96.40	+5.7%	+3.9%	+8.9%	-6.6%	+2.1%	+2.4%
Nov 19	EF Hutton	Maintains	Buy → Buy	—	$114.40	$119.20	+4.2%	+2.8%	-8.8%	-2.6%	+8.0%	-3.2%

Data updated apr 25, 2026 1:14pm · Source: massive.com